Skip to main content

Eurosets announces the first use of its CO2Reset device to treat a hypercapnic patient at the Erasme University Hospital in Brussels on February 21th, 2020. The case was performed by Prof. F. S. Taccone and Dr. L. Nobili who highlighted the safety, ease of use and performance of the device. CO2Reset is a unique medium-flow ECCO2R technology, with a dedicated oxygenator and circuit which are fully PC-coated and validated for use up to five days. This technology received CE mark earlier this year and is now available in Europe and other selected countries. For more information on CO2Reset please click here.